| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.06 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.06 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.07 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.07 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.07 |